Adrian Vivian Sinton Hill PhD

Adrian Hill trained at Trinity College Dublin and Oxford and is now Professor of Human Genetics and Director of the Jenner Institute at Oxford University. His group discovered the ability of heterologous prime-boost immunization to induce potent T cell responses pre-clinically and has developed this approach to phase II clinical trials in Africa. He has also pioneered the use of small rapid clinical trials to provide initial safety and immunogenicity with a range of novel vaccine concepts. To date he has led over 50 clinical trials on new malaria vaccines, almost all designed by his laboratory research team.

In 2005 he founded the Jenner Institute which aims to accelerate public sector vaccine development for infectious diseases and links human and veterinary vaccine development. In 2014 he initiated the first trials of new Ebola vaccines targeting the West Africa strain of the virus and moved these rapidly to field testing. His has published over 500 papers with an h-index (Google Scholar) of 119, is a named inventor on numerous patents and patent filings and has co-founded four university spin-off companies.